Saunders Hollie, Khadka Subekshya, Shrestha Rabi, Baig Hassan Z, Helgeson Scott A
Department of Pulmonary and Critical Care, Mayo Clinic, Jacksonville, FL 32224, USA.
Diseases. 2024 Dec 31;13(1):5. doi: 10.3390/diseases13010005.
BACKGROUND/OBJECTIVES: Peri-intubation hypotension is a known complication of endotracheal intubation. In the hospital setting, peri-intubation hypotension has been shown to increase hospital mortality and length of stay. The use of prophylactic vasopressors at the time of sedation induction to prevent peri-intubation hypotension has been raised. This systematic review and meta-analysis aims to review the safety and efficacy of this practice.
The study was fully registered with PROSPERO on 13 October 2022, and screening for eligibility was initiated on 20 September 2024. Randomized controlled trials, along with retrospective or prospective cohort studies, were included in the search. The terms "peri-intubation hypotension", "vasopressors", "intubation", and "anesthesia induced hypotension" were used to search the title/summary in PubMed, Cochrane Library, and Google Scholar databases. An assessment of bias for each study was conducted using the Newcastle-Ottawa Quality Assessment Scale. The primary outcome was the rate of hypotension peri-intubation. Any complications secondary to hypotension or vasopressors were the secondary outcome.
We identified 13 studies, which were all randomized controlled studies, to include in the final analysis. The risk ratio for preventing peri-intubation hypotension was 1.6 (95% CI, 1.2-2.14) with the use of prophylactic phenylephrine while giving propofol versus no prophylactic vasopressors and 1.28 (95% CI 1.03-1.60) with the use of ephedrine.
These findings suggest that in patients undergoing intubation in the operating room with propofol, prophylactic vasopressors given with induction for intubation decrease the odds of hypotension.
背景/目的:插管期间低血压是气管插管已知的并发症。在医院环境中,插管期间低血压已被证明会增加医院死亡率和住院时间。在诱导镇静时使用预防性血管升压药以预防插管期间低血压的做法已被提出。本系统评价和荟萃分析旨在评估这种做法的安全性和有效性。
该研究于2022年10月13日在PROSPERO上进行了全面注册,并于2024年9月20日开始筛选符合条件的研究。检索纳入了随机对照试验以及回顾性或前瞻性队列研究。使用“插管期间低血压”“血管升压药”“插管”和“麻醉诱导低血压”等术语在PubMed、Cochrane图书馆和谷歌学术数据库中搜索标题/摘要。使用纽卡斯尔-渥太华质量评估量表对每项研究的偏倚进行评估。主要结局是插管期间低血压的发生率。低血压或血管升压药继发的任何并发症为次要结局。
我们确定了13项研究,均为随机对照研究,纳入最终分析。在使用丙泊酚时,预防性使用去氧肾上腺素与不使用预防性血管升压药相比,预防插管期间低血压的风险比为1.6(95%CI,1.2 - 2.14);使用麻黄碱时,风险比为1.28(95%CI,1.03 - 1.60)。
这些发现表明,在手术室接受丙泊酚插管的患者中,诱导插管时给予预防性血管升压药可降低低血压的几率。